About Paradigm Health
Paradigm Health is a Healthcare company based in New York (United States) founded in 2003 by Kent Thoelke. Clinical research healthcare services are provided by Paradigm. It operates on a SaaS (Software-as-a-Service) and Managed Services model. Paradigm Health has raised $203 million across 1 funding round from investors including Mubadala, Arch Venture Partners and General Catalyst. Paradigm Health has completed 1 acquisition, including Deep Lens. Its chief executive, as recorded, is Kent Thoelke. Paradigm Health offers products and services including Intelligent Research Platform. Its focus areas include Clinical Research and Trial Management Solutions. Its legal entity is Paradigm Health Solutions. Its competitors include Evidation, SubjectWell and Dyania Health; 3 of its 3 listed competitors have raised funding.
Company details
Paradigm Health is engaged in transforming clinical research by orienting trials around patient care. The company integrates technology and services with health provider organizations to enhance collaboration and deliver insights. Solutions are provided for sponsors and providers to improve trial efficiency and access to innovative therapies. The platform addresses complexities in the clinical trial ecosystem, aiming to make trials more viable and valuable across healthcare sectors.
- Headquarters New York, United States
- Founders Kent Thoelke
- SectorsHealthcare
- Website paradigm.inc
- Social LinkedIn
- Legal Name Paradigm Health Solutions
Products & Services of Paradigm Health
Paradigm Health offers a comprehensive portfolio of products and services, including Intelligent Research Platform.
A platform connecting patients, providers, and sponsors effectively.
Funding Insights of Paradigm Health
Paradigm Health has successfully raised a total of $203M through 1 strategic funding round. The most recent funding activity was a Series A round of $203 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $203M
- Total Rounds 1
- Last Round Series A — $203M
- First Round $203M
(Jan 2023)
- Investors Count 8
All 1 funding rounds of Paradigm Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $203M | Series A | – | Arch Venture Partners, General Catalyst |
8 investors in total: 8 institutional.
Investors in Paradigm Health
Paradigm Health has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Mubadala, Arch Venture Partners and General Catalyst.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Investment and transformation services for entrepreneurs in technology and finance sectors. | generalcatalyst.com | |||
Investments in life sciences, technology, healthtech, and crypto sectors from global locations. | fprimecapital.com | |||
Corporate backed venture capital fund investing in multiple sectors | gv.com | Mountain View, United States | ||
Seed and early-stage technology companies are funded by Lux Capital. | luxcapital.com | Menlo Park, United States | ||
Magnetic Ventures is focused on transforming healthcare through AI and biotech investments. | 2018 | magneticvc.com | ||
BrightEdge is focused on impact investment in cancer care innovation. | brightedgefund.org | |||
Sovereign wealth fund of United Arab Emirates | 2002 | mubadala.com | Abu Dhabi, United Arab Emirates |
Investor details for Paradigm Health
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Paradigm Health
18 people are tracked at Paradigm Health (12 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Kent Thoelke | Founder & CEO | Leadership |
Michelle Lee | Chief Operating Officer | Leadership |
Harry Hayashi | Head Of Implementation | Leadership |
Elijah Meerson | CTO | Leadership |
Jay Trepanier | Chief Financial Officer | Leadership |
Mark Beckmeyer | Chief Information Security Officer | Leadership |
John Keyes | Vp, Engineering | Leadership |
Deb Rork | Vice President Operations | Leadership |
Kelly Haenlein | Vp, Commercial Business | Leadership |
Jonathan Hirsch | Chief Strategy and Growth Officer | Leadership |
Filiz Muharrem Seimer, MBA, CCRP | Director Clinical Operations | Leadership |
Neel Rane | Head Of Legal | Leadership |
Heather Webb | Clinical Research Lead | Team |
Trista Weber BS, CTR, RT (R) (RT) (CT) | Oncology Data Abstractor | Team |
Christine Personett | Clinical Informaticist | Team |
Corey Sebens | Provider Implementation Lead | Team |
Todd Mayover | Consultant - Virtual Privacy Officer | Team |
Kathy Tirey | Clinical Nurse | Team |
Complete people profiles for Paradigm Health
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Paradigm Health
Paradigm Health has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Deep Lens.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
AI and cloud-based digital pathology platform is developed. | deeplens.ai | Columbus, United States | 2017 | Jan 2023 | •••• |
Complete acquisition details for Paradigm Health
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Paradigm Health
3 dated milestones of Paradigm Health across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Paradigm Health is founded.
- Funding First funding round of $203.0M.
- Acquisition Acquires Deep Lens.
Competitors of Paradigm Health
Paradigm Health has 3 listed competitors in our database, 3 of them funded. They include Evidation, SubjectWell and Dyania Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evidation.com | 2012 | Menlo Park, United States | $259.16M | 196 | Real-world health data is provided for research and decisions. | |
| subjectwell.com | 2012 | Austin, United States | $46.8M | Clinical trials marketplace for patient recruitment solutions is provided. | ||
| dyaniahealth.com | 2019 | Sacramento, United States | $15.3M | Patients for clinical trials are identified through a dedicated platform. |
Detailed competitors of Paradigm Health
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Paradigm Health
The website of Paradigm Health (paradigm.inc) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 41.5% vs previous month
Websites whose visitors overlap most with Paradigm Health. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| myparadigm.com | 100% | 52K | #423,454 | View details | |
| paradigmcorp.com | 51% | 11.2K | #2,106,006 | View details | |
| myparadigmhealth.com | 49% | 5.6K | #3,354,841 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Paradigm Health (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Paradigm Health
Complete news archive for Paradigm Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paradigm Health
Paradigm Health was founded in 2003 and raised its 1st funding round 20 years after it was founded.
Paradigm Health is headquartered in New York, United States. It is registered at New York, New York, United States.
Kent Thoelke is the CEO of Paradigm Health, as recorded in our data. They have also founded this company.
Paradigm Health is a funded company, having raised a total of $203M across 1 funding round to date. The company's 1st funding round was a Series A of $203M, raised on Jan 2023.
Paradigm Health is engaged in transforming clinical research by orienting trials around patient care. The company integrates technology and services with health provider organizations to enhance collaboration and deliver insights. Solutions are provided for sponsors and providers to improve trial efficiency and access to innovative therapies. The platform addresses complexities in the clinical trial ecosystem, aiming to make trials more viable and valuable across healthcare sectors.
Paradigm Health's top competitors include Evidation, Dyania Health and SubjectWell.
Paradigm Health offers Intelligent Research Platform.
Paradigm Health has made 1 acquisition, including Deep Lens.
Paradigm Health has 8 investors. Key investors include Mubadala, Arch Venture Partners, General Catalyst, F-Prime Capital, and Google Ventures.
Paradigm Health operates through Paradigm Health Solutions.